Your Weekly News & Updates
| In This Issue | |
|
|
Apply to join AFHTO’s IHP Advisory Council!
Are you interested in advising AFHTO on the top issues facing IHPs in team-based primary care? Would you like to be a leader in working with IHPs in primary care to advocate for and to speak to the critical role of teams? Would you like to share and spread knowledge and learnings? If yes, please apply to join our IHP Advisory Council!
We invite any IHP in a member team to apply by completing this survey by Friday, January 19. For more information, click here.
Please share this opportunity with providers across teams.
Member stories
Aurora-Newmarket, Southlake Academic FHTs and Georgina NPLC – New OHT combines parts of Simcoe County, York Region
Belleville NPLC- Nurse practitioner coming to Belleville in new year
Centre for Family Medicine FHT – Money for medical interpretation for immigrants, refugees has run out, local groups say
Hamilton FHT – Hamilton FHT creates Patient Relations Program to elevate Patients’ voice
St. Michael’s Hospital Academic FHT- Dr. Tara Kiran receives the North American Primary Care Research Group Mid-Career Researcher Award
News and updates including virtual care with an outside physician is associated with more emergency department visits
- Virtual Visits With Own Family Physician vs Outside Family Physician and Emergency Department Use– JAMA Network Open, November 29, 2023
- Primary care for all: lessons for Canada from peer countries with high primary care attachment – CMAJ, Dec. 4, 2023
- Winter virus season and changes to breast cancer screening in Ontario materials– “Changing The Way We Work” Community of Practice session, OCFP and UofT, Dec. 15, 2023
- Breast Cancer Screening Among Females With and Without Schizophrenia – JAMA Network Open, November 29, 2023
- Greenshield essential medicines program video – per Emma Darby, GreenShield, they’re doing a
program review and some considerable changes to the current criteria are expected, particularly with the income threshold, “so if they’d like to be updated, please feel free to have them contact me at essentialmedicines@greenshield.ca and I’ll add them to the list.” - Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study – The Lancet Infectious Disease, Dec. 14, 2023
- Initiation of opioid agonist therapy after hospital visits for opioid poisonings in Ontario – CMAJ, Dec. 18, 2023
Administrative monetary penalties under PHIPA
The Office of the Information and Privacy Commissioner of Ontario (IPC) sent out notice regarding administrative monetary penalties under PHIPA on Jan. 2. Read more here.
Hypertension Canada and Obesity Canada call for abstracts
They have announced the call for abstracts for their co-hosted conference, to take place in Banff, Alberta Canada April 3-6, 2024. The Call for Abstracts closes January 12, 2024, at 11:50 pm PST. Submit here.
Biosimilars transition period ended
Content below provided by Ontario Health
On behalf of the Ministry of Health we would like to share the following update on Biosimilars.
Effective December 29, 2023, Ontario’s transition period for the Expanded Biosimilars Policy for the originator biologics Copaxone®, Enbrel®, Humalog®, Humira®, Lantus®, NovoRapid®, Remicade®, and Rituxan® through the ODB program will end, with some limited exemptions.
Recognizing that this milestone comes during the holidays, the ministry will allow pharmacists to provide a one-time compassionate minimum supply for an originator prescription using an LU Code between December 29, 2023, and January 30, 2024. This policy change is being made to ensure patients are able to access treatment over the holidays. Pharmacists will still require an updated prescription for patients on Lantus and NovoRapid, as well as Enbrel and Humalog for plaque psoriasis.
Patients with EAP approvals for originator biologics expiring on or after December 1, 2023 and on or before December 28, 2023 will be automatically extended to January 30, 2024. The purpose of this extension is to grant a compassionate supply for patients on EAP-approved originators who did not transition during the 9-month transition period of the biosimilar policy and have not been able to contact their prescriber to obtain a new prescription for a biosimilar.
EO Notice and Frequently Asked Questions
Better Breathing Week 2024, Jan. 16-20, 2024
Developed at the CAMH Azrieli Adult Neurodevelopmental Centre
- Virtual: January 16 – 17, 2024
- In-Person: January 19 – 20, 2024
Hosted by The Lung Health Foundation. Register here.
An Update on HPV-Related Cancers in Canada: Burden, Impact, Prevention, and Counselling Opportunities for Nurses, Jan. 17, 2024
Hosted by Merck. Register here.
ECHO Ontario Child & Youth Mental Health, Jan. 18- June 27, 2024
One-hour sessions are offered weekly on Thursdays with no cost to participate. Register here.
Meaningful Digital Transformation: Advancing Sustainability and Wellness in the Digital Sphere, Jan. 25, 2024
Hosted by TechSoup Canada and Wholegrain Digital. Register here.
Family Medicine Summit, Jan. 26-27, 2024
Virtual event hosted by OCFP. Register here.
Leave a Reply